- 22nd annual Meeting of the European Venous Forum
- 30 June – 2 July 2022
Provisional Scientific Programme
Please contact Womblab srl with any registration queries. Womblab are acting on behalf of the EVF
Download the Programme/Book of Abstracts
THURSDAY 30 JUNE 2022
| 08.00-08.30 | Industry Video Session: (5 minute presentation, 5 minute discussion) 3 presentations
Chair: Marzia Lugli |
| 08.30-10.30 | Abstract Session 1: Venous Thromboembolism
(10 minute presentation, 10 minute discussion) Chairs: Oscar Maleti, Andrew Nicolaides |
| 08.30-08.50 1.1 | Predictive value of cellular indices for adverse outcomes in VTE patients. Study from RIETE (Registro Informatizado Enfermedad tromboembolica) Registry.
Fakiha Siddiqui*1; Alfonso Tafur2; Mushtaq Hussain3; Alberto García-Orteg4; Pablo Demelo-Rodrígu5; José Antonio Nieto6; Esther Usandizaga7; Jawed Fareed8; Manuel Monreal9 1Loyola University Chicago, Maywood, USA; 2NorthShore University Health Systems, Skokie, USA; 3Dow University of Health Sciences, Karachi, Pakistan; 4Hospital Universitari i Politècnic La Fe, Valencia, Spain; 5Hospital General Universitario Gregorio Marañón, Madrid, Spain; 6Hospital General Virgen de la Luz, Cuenca, Spain; 7Hospital Sant Joan Despí-Moises Broggi, Barcelona, Spain; 8Cardiovascular Research Institute, Loyola University Chicago,, Maywood, USA; 9Hospital Universitari Germans Trias i Pujol., Barcelona, Spain Submitted for the EVF Prize |
| 08.50-09.10 1.2 | Treating acute, subacute, and chronic deep vein thrombosis using mechanical thrombectomy: Six-month outcomes from The United States CLOUT Registry.
Nicolas Mouawad*. McLaren Health System, Bay City, USA |
| 09.10-09.30 1.3 | High incidence of thrombosis in patients with severe covid19 infection: LMWH at intermediate doses does not reduce the risk of thrombosis but is associated with lower mortality.
Marta Camats Terré*; Teresa Solanich Valldaura; Granada Perea Duran; Luz Muñoz Marin; Rita Subirana Bofill; Anna Valle Beltran; Anna Artigas Soler; Kinu Reyes Kim; Anna Gasulla Rodríguez; Juan Gabriel Castro Ríos; Juan Carlos Oliva Morera Parc Taulí Hospital Universitari, Sabadell, Spain |
| 09.30-09.50 1.4 | The effects of post-thrombotic venous outflow obstruction on cardiac function during exercise.
Rachael Morris*1; Bram Ruijsink1; Richard Bruce1; Philip Marino2; Bhashkar Mukherjee2; Aimee Brame2; Reza Razavi1; Alberto Smith1; Stephen Black1 1Kings College London, London, UK; 2St Thomas’ Hospital, London, UK Submitted for the EVF Prize |
| 09.50-10.10 1.5
VIRTUAL |
Long-term results of tinzaparin for the treatment of superficial vein thrombosis of the lower limbs.
Chrysanthi Papageorgopoulou*; Konstantinos Nikolakopoulos; Spyros Papadoulas; Stavros Kakkos. University Hospital of Patras, Patras, Greece |
| 10.10-10.30 1.6 | Development of an international standard set of outcome measures for patients with venous thromboembolism: A Report of The International Consortium For Health Outcomes Measurement (ICHOM) Venous Thromboembolism Working Group.
Adam Gwozdz*1; Cindy de Jong2; Luz Fialho3; Frieda Sossi3; Theerawich Likitabhorn4; Stephen Black1; Frederikus Klok2. 1Academic Department of Vascular Surgery, School of Cardiovascular Medicine and Science, King’s Colle, London, UK; 2Department of Medicine, Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, Netherlands; 3International Consortium for Health Outcomes Measurement, London, UK; 4International Consortium for Health Outcomes Measurement, Boston, USA Submitted for the EVF Prize |
| 10.30-11.00 | Refreshments | View ePoster Presentations | Visit Exhibition |
| 11.00-13.00 | Abstract Session 2: Venous Thromboembolism
(10 minute presentation, 10 minute discussion) Chairs: Stavros Kakkos, Raffaele Pesavento |
| 11.00-11.20 2.1 | Sulodexide as a complimentary drug on the management of acute deep venous thrombosis.
Erasto Aldrett Lee*1; Nora Enid Lecuona Huet2 1Hospital Lomas de San Luis, San Luis Potosí, Mexico; 2Hospital Lomas de San Luis, Mexico City, Mexico |
| 11.20-11.40 2.2
VIRTUAL |
Implementation of a direct oral anticoagulant perioperative interruption protocol and accuracy of the DOAC urine dipstick.
Guillermo Tafur*1; Luis Paz Rios2; Thomas Gniadek3; Jeanine Walenga4; Jawed Fareed4; Marisa Durante3; Job Harenberg5; Alfonso Tafur3 1Northwestern University, Evanston, USA; 2Massachusetts General Hospital, Boston, USA; 3NorthShore University Health System, Evanston, USA; 4Loyola University Medical Center, Maywood, USA; 5DOASENSE GmbH, Heidelberg University, Heidelberg, Germany Submitted for the EVF Prize |
| 11.40-12.00 2.3 | Readability of patient educational materials in venous thrombosis. Analysis of the 2021 ESVS guidelines and comparison with other medical societies information.
Enrique San Norberto*1; Álvaro Revilla1; José-Antonio Brizuela1; Manuel Diez1; James Taylor2; Carlos Vaquero1. 1Valladolid University Hospital, Valladolid, Spain; 2Valencia General University Hospital, Valencia, Spain |
| 12.00-12.20 2.4 | Predictive Role Of Blood Cellular Indices And Endogenous Glycosaminoglycans As Determinants Of Inflammatory Biomarkers In Acute Pulmonary Embolism.
Fakiha Siddiqui*; Bulent Kantarcioglu*; Amir Darki; Joseph Lewis; Trent Reed; Omer Iqbal; Walter Jeske; Jawed Fareed Loyola University Chicago, Chicago, USA |
| 12.20-12.40 2.5 | Systematic review and meta-analysis of venous thromboembolism prophylaxis after endovenous varicose vein surgery.
Benedict Turner*; Matthew Machin; Sara Jasionowska; Alun H Davies Charing Cross Hospital, Imperial College London, London, UK Submitted for the EVF Prize |
| 12.40-13.00 2.6 | Impact of standard catheter directed thrombolysis versus ultrasound assisted thrombolysis on total or subtotal pulmonary arterial occlusions in patients with pulmonary embolism. A secondary analysis of the SUNSET Trial.
Efthymios Avgerinos*1; Elizabeth Andraska1; Riyaz Bashir2; Wisam Jaber3; Joan Lacomis1; Michael McDaniel3; Charles Ross4; Rabih Chaer1. 1University of Pittsburgh Medical Center, Pittsburgh, USA; 2Division of Cardiovascular Disease, Lewis Katz School of Medicine at Temple University, Philadelphia, USA; 3Emory University, Atlanta, USA; 4Piedmont Heart Center, Atlanta, USA |
| 13.00-14.00 | View ePoster Presentations (4 minute presentations)
Chair: Andrew Nicolaides, Erika Mendoza, Efthymios Avgerinos, Attilo Cavezzi |
| 13.00-14.00 | Lunch | Visit Exhibition |
| 13.15-14.00 | “Meet the Experts” Session
Chairs: Efthymios Avgerinos, Domenico Baccellieri |
| Iliac stenting: how I do it. Stephen Black (UK) | |
| Thermal vs Non-thermal ablation: when and how I do it. Manjit Gohel (UK) | |
| 14.00-15.00 | Industry Session 1 |
| 15.00-16.00 | Didactic Session 1: Advances in the management of acute DVT
Chairs: Niels Baekgaard, A Ierardi |
| 15.00-15.15
VIRTUAL |
Early Thrombus Removal: who, when and how. Gerard O’Sullivan (Ireland) |
| 15.15-15.30 | Acute DVT complicating MT syndrome. Michael Lichtenberg (Germany) |
| 15.30-15.45 | Why to be aggressive in young patient affected by DVT. Marzia Lugli (Italy) |
| 15.45-16.00 | Which compression in acute DVT and how to apply. Giovanni Mosti (Italy) |
| 16.00-16.30 | Refreshments | Visit Exhibition | View ePoster Presentations |
| 16.30-17.30 | Didactic Session 2: Advances in the management of chronic venous insufficiency
Chairs: Athanasios Giannoukas, Giovanni Agus |
| 16.30-16.45 | Hypodermitis, skin inflammation: how to treat. Lourdes Reina Gutierrez (Spain) |
| 16.45-17.00 | How to measure PTS disease and outcomes after operative treatments. Sabina Villalta (Italy) |
| 17.00-17.15 | Which pharmacological therapy after stenting. Mario Bazzan (Italy) |
| 17.15-17.30 | Chronic venous disease and diabetic microangiopathy: pathophysiology and commonalities. Marie Josee van Rijn (Netherlands) |
| 17.30-18.30 | Industry Session 2 |
FRIDAY 1 JULY 2022
| 08.00-08.30 | Industry Video Session: (5 minute presentation, 5 minute discussion) 3 presentations
Chair: Giovanni Lipari (Italy) |
| 08.30-10.30 | Abstract Session 3: Iliac occlusion and pelvic congestion syndrome, Cyanoacrylate, Epidemiology
(10 minute presentation, 10 minute discussion) Chairs: Dominik Heim, Gennaro Quarto |
| 08.30-08.50 3.1 | Patency rates and predictors for re-intervention after stenting for acute or chronic deep vein thrombosis: a retrospective observational study.
Jay M. Bakas*; Adriaan Moelker; Catherine van Montfrans; Marie Josee E. van Rijn Erasmus Medical Center, Rotterdam, Netherlands Submitted for the EVF Prize |
| 08.50-09.10 3.2 | Identification of patients with outflow obstruction most likely to benefit from iliac stenting.
Fedor Lurie*. Jobst Vascular Institute, Toledo, USA |
| 09.10-09.30 3.3 | Hybrid ilio-femoral recanalization after injection for drug abuse obstruction: a single centre experience.
Elisa Munari*; Marzia Lugli; Matteo Longhi; Oscar Maleti. Hesperia Hospital, Modena, Italy Submitted for the EVF Prize |
| 09.30-09.50 3.4 | Endovascular treatment of pelvic congestive syndrome, literature review. Is pharmacomechanical ablation of gonadal veins an alternative to classic embolization?
Eliseo Candela Beltran*. Hospital de Manises, Valencia, Spain Submitted for the EVF Prize |
| 09.50-10.10 3.5 | Evolution of the epidemiology and management of chronic venous disease in the UK.
Safa Salim*1; Mahsa Mazidi1; Roberto Fernandez Crespo1; Estelle Collin2; Sarah Onida1; Joanna Chirol2; Alun H Davies1. 1Imperial College London, London, UK; 2Servier, Paris, France Submitted for the EVF Prize |
| 10.10-10.30 3.6 | Correlation Amongst Transvaginal And Transabdominal Duplex And CT Angiogram For Pelvic Venous Insufficiency And Leg Varicosities
Lourdes Reina Gutierrez*1; Angel Sanchez Guerrero2; Luis Albeniz1; Jose Ignacio Fernandez Solares1; Agnieszka Nowak Tarnawska1; Carlos Barrio Rodriguez1; Angela Miguel Morrondo1; Aurora Florez-Gonzalez1; Alfonso Sanjuanbenito-Reina3; Jose Antonio Gonzalez-Fajardo2; 1Hospital Central de la Cruz Roja, Madrid, Spain; 2Hospital Universitario 12 de Octubre, Madrid, Spain; 3Universidad Autonoma, Madrid, Spain |
| 10.30-11.00 | Refreshments | View ePoster Presentations | Visit Exhibition |
| 11.00-12.00 | Industry Session 3 |
| 12.00-12.30 | EVF Invited Lecture
Chair: Oscar Maleti (Italy) Introduction by Oscar Maleti |
| COVID-19 and Thrombosis: basis and management of an incendiary duality. Ismail Elalamy (France) | |
| 12.30-13.00 | Didactic Session 3: Guidelines of Chronic Venous Disease
Chairs: Tomasz Urbanek, Gaetano Lanza |
| 12.30-12.45 | Comparison of recent guidelines for Chronic Venous Disease. Dominik Heim (Switzerland) |
| 12.45-13.00 | What is not in the Guidelines. Imre Bihari (Hungary) |
| 13.00-14.00 | Refreshments | View ePoster Presentations (4 minute presentations)
Chairs: Andrew Nicolaides, Erika Mendoza, Efthymios Avgerinos, Attilo Cavezzi |
| 13.15-14.00 | Industry Workshop |
| 13.00-14.00 | Visit Exhibition |
| 14.00-15.00 | EVF Annual General Meeting (Members Only) |
| 15.00-16.00 | Joint EVF/AVF Session Debate:
Chairs: Marianne Vandendriessche, Lugli Marzia |
| 15.00-15.30 | Evaluation of patients with CVI should include pelvic venous imaging in addition to lower extremity imaging.
For: Kathleen Ozsvath (USA), AVF | Against: Armando Mansilha (Portugal) EVF |
| 15.30-16.00
VIRTUAL |
Venoactive drugs are useful in the management of patients with chronic venous disease in all stages of CEAP.
For: Andrew Nicolaides, EVF | Against: Nicos Labropoulos (AVF) |
| 16.00-16.30 | Refreshments| Visit ePoster Presentations | Visit Exhibition |
| 16.30-17.30 | Industry Session 4 |
| 17.30-18.30 | Prize winning papers from the Japanese Society of Phlebology, American Venous Form and American Vein and Lymphatic Society
(10 minute presentation, 10 minute discussion) Chairs: Erika Mendoza, Angelo Santoliquido |
| 17.30
VIRTUAL |
Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients with COVID-19 in Japan
Yugo Yamashita: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan Norikazu Yamada: Department of Cardiology, Kuwana City Medical Center, Kuwana, Japan Mo Makoto: Department of Cardiovascular Surgery, Yokohama Minami Kyosai Hospital, Kanagawa, Japan JSP Prize paper |
| 17.50 | Is Oedema Underrecognized in Superficial Venous Disease Patients?
Sophia C. Weldon, Christopher Pittman, Stachyse Stanis, Anna M. Wright. Vein911 Vein Treatment Centers, Tampa, Florida, USA AVLS Prize Paper |
| 18.10 | Markers of pulmonary hypertension in patients with submassive pulmonary embolism undergoing catheter thrombolysis compared to anticoagulation alone: a secondary analysis of the SUNSET sPE trial.
Andraska EA1, Bonaroti J2, Zhang Y3, Rivera-Lebron B3, Chaer RA1, Avgerinos ED1 1UPMC, Department of Surgery, Division of Vascular Surgery; Pittsburgh, Pennsylvania, United States 2UPMC, Department of Surgery; Pittsburgh, Pennsylvania, USA 3UPMC, Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine; Pittsburgh, Pennsylvania, USA AVF Prize paper |
SATURDAY 2 JULY 2022
| 08.30-10.30 | Abstract Session 4: Compression, microcirculation, telangiectasia, varicose veins
(10 minute presentation, 10 minute discussion) Chairs: Imre Bihari, Marco Viani |
| 08.30-08.50 4.1 | A randomized trial of moderate (class 2), high (class 3) and very high (class 4) elastic compression in the prevention of recurrence of venous ulceration.
Dragan Milic*1; Sasa Zivic2; Milan Lazarevic1; Dragan Bogdanovic3; Bekim Ademi4; Isidora Milic5. 1University Clinical Centre Nis, Medical school University of Nis, Nis, Serbia; 2University Clinical Centre Nis, Nis, Serbia; 3University of Novi Pazar, Novi Pazar, Serbia; 4Clinical Centre Pristina, Kosovo*, Presevo, Serbia; 5Medical school University of Nis, Nis, Serbia |
| 08.50-09.10 4.2 | COmpressioN Following Endovenous TreatmenT of Incompetent Varicose Veins (CONFETTI).
A Belramman*; R Bootun; TRA Lane; CV Riga; C Aylwin; J Shalhoub; U Jaffer; C Bicknell; AH Davies. Imperial College London, London, UK Submitted for the EVF Prize |
| 09.10-09.30 4.3 | Microcirculatory alterations in chronic venous disorder — Observation in C0s patients (CEAP Classification).
Eliete Bouskela*1; Bernardo Cunha Senra Barros2; Carlos Eduardo Virgini Magalhães1; Daniel Alexandre Bottino1. 1State University of Rio de Janeiro, Rio de Janeiro, Brazil; 2Federal University of Rio de Janeiro State, Rio de Janeiro, Brazil |
| 09.30-09.50 4.4 | Prevalence of chronic venous disease in primary care centers in Azerbaijan: The VEINSCOPE Study.
Farhad Aghayev*. Baku Phlebological Center, Baku, Azerbadijan |
| 09.50-10.10 4.5
VIRTUAL |
Frequency of postoperative neuropathies after phlebectomy and minimal invasive treatment methods for varicose veins
Anna Ūdre*1; Solvita Bērziņa2; Patricija Ivanova3; Ints Ūdris3 1Riga East Clinical University Hospital, University of Latvia, Riga, Latvia; 2Riga East Clinical University Hospital, Riga, Latvia; 3Riga East Clinical University Hospital, Baltic Vein Clinic, University of Latvia, Riga, Latvia |
| 10.10-10.30 4.6 | N-butyl-2-cyanoacrylate glue ablation as a single-catheter procedure for the great saphenous vein insufficiency treatment – 5-years follow-up.
Michal Juszynski*; Jan Wawszczak; Grzegorz Madycki. Centre of Postgraduate Medical Education, Warsaw, Poland Submitted for the EVF Prize |
| 10.30-11.00 | View ePoster Presentations and visit Exhibition |
| 11.00-13.00 | Abstract Session 5: Congenital malformation, lymphatics, complications of thrombolysis, obesity, AI Guidance
(10 minute presentation, 10 minute discussion) Chairs: Armando Mansilha, Francesco Stillo |
| 11.00-11.20 5.1 | Remote expert DVT triaging of novice-user compression sonography with AI guidance.
Jonas Oppenheimer1; Ramin Mandegaran2; Sven Mischkewitz1; Fouad Al Noor3; Andrea Adler4; Stephan Singöhl4; Mattias Heinrich5; Bernhard Kainz6; Stavros Spiliopoulos7; George Geroulakos7; Efthymios Avgerinos*7 1ThinkSono GmbH, Potsdam, Germany; 2Central Alberta Medical Imaging Services, Red Deer, Canada; 3ThinkSono GmbH, London, UK; 4Klinikum Magdeburg, Magdeburg, Germany; 5University of Lübeck, Lübeck, Germany; 6FAU Erlangen-Nürnberg, Erlangen, Germany; 7Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece |
| 11.20-11.40 5.2
|
Benefit of an adjustable compression system for the reduction of oedema (akro study)- preliminary results.
Gabriele Faerber*1; Birgit Kahle2; Tobias Hirsch3; Andrzej Szuba4 1Zentrum für Gefäßmedizin, Hamburg, Hamburg, Germany; 2Universitäts-Klinikum Schleswig-Holstein Campus Lübeck, Luebeck, Germany; 3Praxis für Innere Medizin und GEfaesskrankheiten, Halle, Germany; 4Uniwersytecki Szpital Kliniczny im.Jana Mikulicza-Radeckiego we Wrocławiu, Wroclav, Poland |
| 11.40-12.00 5.3 | Effect of ruscus extract, hesperidin methyl chalcone and vitamin C on human lymphatic smooth muscle cells contraction.
Nicolas Monjotin*1; Guillaume Tenca2 1Castres, France; 2QIMA Life Sciences, Gencay, France |
| 12.00-12.20 5.4 | Peri-operative management of anticoagulation and bleeding in patients undergoing CDT for acute iliofemoral DVT.
Katherine Creeper*; Katie White; Stephen Black; Narayanan Thulasidasan; Karen Breen. Guy’s and St Thomas’ NHS Foundation Trust, London, UK |
| 12.20-12.40 5.5 | A Systematic Review Of Compression Following Treatment Of Superficial Venous Incompetence
Abduraheem Mohamed1; Sundus Mohamed*2; Simran Thadani3; Misha Sidapra1; George Smith1; Ian Chetter1; Daniel Carradice1 1Hull University Teaching Hospitals, Hull, UK; 2Leeds University Teaching Hospitals, Leeds, UK; 3Hull York Medical School, Hull, UK Submitted for the EVF Prize |
| 12.40-13.00 5.6
|
Stenting Of Non-thrombotic Iliac Vein Lesions: Long-term Patency Rate
Matteo Longhi*; Marzia Lugli; Elisa Munari; Oscar Maleti. Hesperia Hospital, Modena, Italy |
| 13.00-14.00 | Didactic Session 4: Management of lymphatic disorders
Chairs: Oscar Maleti, Albert Claude Benhomou |
| 13.00-13.15 | Quality of life after vascularised lymph node transfer or lymphovenous anastomosis in patients with lower limb lymphoedema — a systematic review. Sarah Onida (UK) |
| 13.15-13.30 | Lymphoscintigraphic pattern in CEAP 0s: Role Of deep lymphatic circulation. Alberto Maccio (Italy) |
| 13.30-13.45 | Role of the vein in the long-term patency of microsurgical lymphatic-venous by-pass (LVB) surgery in lymphedema treatment. Francesco Boccardo (Italy) |
| 13.45-14.00 | Differential diagnosis of venous ulcer. If it is not a venous ulcer, what is it? Daciana Branisteanu (Romania) |
| 14.00 | Presentation of EVF Prizes. Oscar Maleti
Presentation of 2023 Meeting. Erika Mendoza End of meeting |